KMT2D and diffuse large B-cell lymphoma: Functionally, KMT2D mutations occur early during tumorigenesis in DLBCL by inhibiting global H3K4 methylation, perturbing the expression of tumor suppressor genes that control B-cell activating pathways 4, 26.